Binding Site Information of Target
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T13491 | Target Info | |||
Target Name | Solute carrier family 29 member 1 (SLC29A1) | ||||
Synonyms | SLC29A1; Nucleoside transporter, es-type; Nucleoside transporter 1; Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter; Equilibrative NBMPR-sensitive nucleoside transporter; ENT1 | ||||
Target Type | Successful Target | ||||
Gene Name | SLC29A1 | ||||
UniProt ID |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
Ligand Name: Dilazep | Ligand Info | |||||
Structure Description | Human equilibrative nucleoside transporter-1, dilazep bound | PDB:6OB7 | ||||
Method | X-ray diffraction | Resolution | 2.30 Å | Mutation | Yes | [1] |
PDB Sequence |
PQDRYKAVWL
16 IFFMLGLGTL26 LPWNFFMTAT36 QYFTNRLDMS46 QNNSLSAIFN81 NVMTLCAMLP 91 LLLFTYLNSF101 LHQRIPQSVR111 ILGSLVAILL121 VFLITAILVK131 VQLDALPFFV 141 ITMIKIVLIN151 SFGAILQGSL161 FGLAGLFPAS171 YTAAIMSGQG181 LAGFFASVAM 191 ICAIASGSEL201 SESAFGYFIT211 ACAVIILTII221 CYLGLPRLEF231 YRYYQQLKLS 281 IKAILKKISV291 LAFSVCFIFT301 ITIGMFPAVT311 VEVKSSIAGS321 STWERYFIPV 331 SCFLTFNIFD341 WLGRSLTAVF351 MWPGKDSRWL361 PSLVLARLVF371 VPLLLLCNIK 381 PRRYLTVVFE391 HDAWFIFFMA401 AFAFSNGYLA411 SLCMCFGPKK421 VKPAEAETAG 431 AIMAFFLCLG441 LALGAVFSFL451 F
|
|||||
|
THR25
4.937
LEU26
2.522
TRP29
1.981
ASN30
2.970
MET33
2.217
THR34
2.008
THR36
2.603
ASN81
3.550
MET84
2.226
THR85
2.687
ALA88
3.530
MET89
2.611
LEU92
2.722
ASN151
3.044
GLY154
3.801
GLN158
2.299
PHE162
3.957
GLN180
3.519
ALA183
4.637
|
|||||
Ligand Name: S6-nitrobenzyl mercaptopurine riboside | Ligand Info | |||||
Structure Description | Human equilibrative nucleoside transporter-1, S-(4-nitrobenzyl)-6-thioinosine bound, merohedrally twinned | PDB:6OB6 | ||||
Method | X-ray diffraction | Resolution | 2.90 Å | Mutation | Yes | [1] |
PDB Sequence |
PQDRYKAVWL
16 IFFMLGLGTL26 LPWNFFMTAT36 QYFTNRLDMN74 SLSAIFNNVM84 TLCAMLPLLL 94 FTYLNSFLHQ104 RIPQSVRILG114 SLVAILLVFL124 ITAILVKVQL134 DALPFFVITM 144 IKIVLINSFG154 AILQGSLFGL164 AGLFPASYTA174 AIMSGQGLAG184 FFASVAMICA 194 IASGSELSES204 AFGYFITACA214 VIILTIICYL224 GLPRLEFYRY234 YQQSIKAILK 287 KISVLAFSVC297 FIFTITIGMF307 PAVTVEVKSS317 RYFIPVSCFL335 TFNIFDWLGR 345 SLTAVFMWPG355 KDSRWLPSLV365 LARLVFVPLL375 LLCNIKPRRY385 LTVVFEHDAW 395 FIFFMAAFAF405 SNGYLASLCM415 CFGPKKVKPA425 EAETAGAIMA435 FFLCLGLALG 445 AVFSF
|
|||||
|
GLY24
3.614
THR25
2.741
LEU26
2.072
PRO28
3.118
TRP29
2.324
ASN30
4.484
MET33
4.028
MET89
4.334
LEU92
2.372
LEU116
4.622
ILE119
2.406
PHE123
4.290
ILE150
2.548
ASN151
3.092
GLY154
2.564
ALA155
4.193
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structures of human ENT1 in complex with adenosine reuptake inhibitors. Nat Struct Mol Biol. 2019 Jul;26(7):599-606. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.